Cardio Diagnostics Holdings, Inc.
CDIO
$2.65
$0.3314.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -57.31% | -55.74% | -50.13% | -39.51% | 105.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -57.31% | -55.74% | -50.13% | -39.51% | 105.29% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -57.31% | -55.74% | -50.13% | -39.51% | 105.29% |
| SG&A Expenses | -29.40% | -25.49% | -29.01% | -42.30% | 14.69% |
| Depreciation & Amortization | 351.43% | 578.13% | 352.08% | 239.06% | 27.60% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.64% | -22.24% | -26.13% | -39.79% | 15.72% |
| Operating Income | 22.49% | 22.10% | 26.01% | 39.79% | -15.51% |
| Income Before Tax | 22.49% | 20.61% | 28.76% | 49.12% | -0.08% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 22.49% | 20.61% | 28.76% | 49.12% | -0.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.49% | 20.61% | 28.76% | 49.12% | -0.08% |
| EBIT | 22.49% | 22.10% | 26.01% | 39.79% | -15.51% |
| EBITDA | 24.77% | 24.44% | 28.75% | 42.85% | -13.44% |
| EPS Basic | 64.68% | 64.80% | 67.15% | 77.52% | 52.35% |
| Normalized Basic EPS | 64.68% | 66.81% | 69.22% | 77.44% | 52.17% |
| EPS Diluted | 64.68% | 64.80% | 67.15% | 77.52% | 52.35% |
| Normalized Diluted EPS | 64.68% | 66.81% | 69.22% | 77.44% | 52.17% |
| Average Basic Shares Outstanding | 95.39% | 123.65% | 123.32% | 120.19% | 112.09% |
| Average Diluted Shares Outstanding | 95.39% | 123.65% | 123.32% | 120.19% | 112.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |